New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2014
10:00 EDTRADRite Aid benefiting from generic rebid and Cymbalta launch, says Cleveland
Cleveland Research said Rite Aid's gross profits are benefiting from a recent RFP for its generic business which will likely result in savings of 3% and the Cymbalta generic launch that is running above expectations, which should offset reimbursement pressures.
News For RAD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 5, 2015
08:34 EDTRADRite Aid reports Q4 SSS up 4.5%
Subscribe for More Information
08:31 EDTRADRite Aid reports February SSS up 3.3% y/y
Subscribe for More Information
February 23, 2015
06:06 EDTRADStocks with implied volatility movement; JNJ NUGT
Stocks with implied volatility movement; Halliburton (HAL) 32, Rite Aid (RAD) 34 according to iVolatility.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use